The American journal of clinical nutrition · 2026
Low folate status and related polymorphisms are associated with lower sperm quality in healthy males: The Lifestyle and Environmental Determinants of Seminogram and Other Male Fertility-Related Parameters (Led-Fertyl) cross-sectional study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Eigbefoh-Addeh Ailende, Salas-Huetos Albert, Ramos-Rodríguez Carla, Santos-Calderón Luis A, Agarwal Rashmi, Salas-Salvadó Jordi, Babio Nancy, McCann Adrian, Ueland Per M, Murphy Michelle M
Аннотация
BACKGROUND: Folate-mediated one-carbon metabolism is essential for deoxyribonucleic acid synthesis, methylation, and genomic integrity during spermatogenesis.
OBJECTIVES: To study the associations between the status of folate, cobalamin, homocysteine, single nucleotide polymorphisms (SNPs) affecting folate-mediated one-carbon metabolism, and sperm quality.
METHODS: In this cross-sectional study, 197 healthy males (18‒40 y) were recruited between 2021 and 2023. Plasma folate, red blood cell folate (RBCF), plasma cobalamin, total homocysteine, and SNPs affecting folate and cobalamin status were determined. Sperm quality parameters were assessed by World Health Organization 2010 criteria. Associations between B-vitamin status, genetic polymorphisms, and sperm quality parameters were assessed using multivariable linear and logistic regression analysis.
RESULTS: Median (25th and 75th percentiles) plasma folate was 14.2 (11.0, 17.8) nmol/L, and RBCF was 678.2 (582.3, 785.0) nmol/L. Deficiency, plasma folate <7 nmol/L and RBCF (<340 nmol/L), occurred in 4.6% [95% confidence interval (CI): 2.4%, 8.5%] and 2.6% (95% CI: 1.1%, 5.8%) of participants, respectively. Lowest compared with highest tertile plasma folate (<11.9 nmol/L compared with ≥17.0 nmol/L) and RBCF (<625.0 nmol/L compared with ≥742.1 nmo/L) were associated with lower sperm count [B = ‒0.428, standard error (SE): 0.196 and B = ‒0.459, SE: 0.183, respectively] and higher odds of altered seminogram [odds ratio: (OR): 3.4; 95% CI: 1.4, 8.2 and OR: 2.3; 95% CI: 1.0, 5.3, respectively]. Median (25th and 75th percentiles) plasma cobalamin was 239.1 (203.0, 282.3) pmol/L and plasma total homocysteine was 9.6 (7.8, 11.5) μmol/L. Cobalamin deficiency (<148 pmol/L) and plasma total homocysteine >15 μmol/L were observed in 1.5% (95% CI: 0.5%, 4.4%) and 5.6% (95% CI: 3.1%, 9.7%) of participants, respectively. Neither was associated with sperm quality parameters. The MTHFD1 1958AA compared with GG genotype was associated with reduced progressive motility (B = ‒7.7%, SE: 3.8), and higher odds of altered seminogram (OR: 4.4; 95% CI: 1.4, 13.7).
CONCLUSIONS: Low folate status is negatively associated with sperm quality. The MTHFD1 1958AA genotype may be negatively associated with sperm quality.
OBJECTIVES: To study the associations between the status of folate, cobalamin, homocysteine, single nucleotide polymorphisms (SNPs) affecting folate-mediated one-carbon metabolism, and sperm quality.
METHODS: In this cross-sectional study, 197 healthy males (18‒40 y) were recruited between 2021 and 2023. Plasma folate, red blood cell folate (RBCF), plasma cobalamin, total homocysteine, and SNPs affecting folate and cobalamin status were determined. Sperm quality parameters were assessed by World Health Organization 2010 criteria. Associations between B-vitamin status, genetic polymorphisms, and sperm quality parameters were assessed using multivariable linear and logistic regression analysis.
RESULTS: Median (25th and 75th percentiles) plasma folate was 14.2 (11.0, 17.8) nmol/L, and RBCF was 678.2 (582.3, 785.0) nmol/L. Deficiency, plasma folate <7 nmol/L and RBCF (<340 nmol/L), occurred in 4.6% [95% confidence interval (CI): 2.4%, 8.5%] and 2.6% (95% CI: 1.1%, 5.8%) of participants, respectively. Lowest compared with highest tertile plasma folate (<11.9 nmol/L compared with ≥17.0 nmol/L) and RBCF (<625.0 nmol/L compared with ≥742.1 nmo/L) were associated with lower sperm count [B = ‒0.428, standard error (SE): 0.196 and B = ‒0.459, SE: 0.183, respectively] and higher odds of altered seminogram [odds ratio: (OR): 3.4; 95% CI: 1.4, 8.2 and OR: 2.3; 95% CI: 1.0, 5.3, respectively]. Median (25th and 75th percentiles) plasma cobalamin was 239.1 (203.0, 282.3) pmol/L and plasma total homocysteine was 9.6 (7.8, 11.5) μmol/L. Cobalamin deficiency (<148 pmol/L) and plasma total homocysteine >15 μmol/L were observed in 1.5% (95% CI: 0.5%, 4.4%) and 5.6% (95% CI: 3.1%, 9.7%) of participants, respectively. Neither was associated with sperm quality parameters. The MTHFD1 1958AA compared with GG genotype was associated with reduced progressive motility (B = ‒7.7%, SE: 3.8), and higher odds of altered seminogram (OR: 4.4; 95% CI: 1.4, 13.7).
CONCLUSIONS: Low folate status is negatively associated with sperm quality. The MTHFD1 1958AA genotype may be negatively associated with sperm quality.